Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
9916852
Reference Type
Journal Article
Title
Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period
Author(s)
Hay, ID; Hutchinson, ME; Gonzalez-Losada, T; Mciver, B; Reinalda, ME; Grant, CS; Thompson, GB; Sebo, TJ; Goellner, , JR
Year
2008
Is Peer Reviewed?
1
Journal
Surgery
ISSN:
0039-6060
EISSN:
1532-7361
Volume
144
Issue
6
Page Numbers
980-7; discussion 987-8
Language
English
PMID
19041007
DOI
10.1016/j.surg.2008.08.035
Abstract
BACKGROUND:
The study aims were to characterize patients with papillary thyroid microcarcinoma (PTM) and to describe post-surgical outcome.
METHODS:
Nine hundred PTM patients had initial treatment at Mayo Clinic during 1945-2004. Mean follow-up was 17.2 years. Recurrence and mortality details were derived from a computerized database.
RESULTS:
Median tumor size was 7 mm; 98% were intrathyroidal. 273 patients (30%) had neck nodal involvement; 3 (0.3%) had distant metastases at diagnosis. Seven-hundred and sixty-five (85%) underwent bilateral lobar resection (BLR; total-, near-total, or bilateral subtotal thyroidectomy). Regional nodes were removed by either "node picking" (27%) or compartmental dissection (23%). Tumor resection was incomplete in 5 (0.6%). Radioiodine remnant ablation (RRA) was performed in 155 (17%). Overall survival did not differ from expected for an age and gender matched control group (P = .96); 3 patients (0.3%) died of PTM. None of the 892 patients with initial complete tumor resection developed metastatic spread during 20 postoperative years. Twenty-year and 40-year tumor recurrence rates were 6% and 8%, respectively. Higher recurrence rates were seen with multifocal tumors (P = .004) and node-positive patients (P < .001). Neither more extensive surgery nor RRA reduced recurrence rates compared to unilateral lobectomy.
CONCLUSION:
More than 99% of PTM patients are not at risk of distant spread or cancer mortality. RRA after BLR did not improve postoperative outcome.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity